Sanguine Corporation Meets With FDA To Define PHER-O2 Regulatory Path

PASADENA, Calif.--(BUSINESS WIRE)--Second graph, first sentence of release dated Dec. 5, 2006 should read: PIRIBO, a well known BioPharma Industry analyst, reported that the annual organ and tissue transplantation market in the U.S. was estimated at $11.7 billion in 2005 and is expected to rise at an average annual growth rate (AAGR) of 5.2% to $15.1 billion by 2010 (sted PRIBO, a well known BioPharma Industry analyst, reported that the annual organ and tissue transplantation market in the U.S. was estimated at $11.7 billion in 2005 and is expected to rise at an average annual growth rate (AAGR) of 5.2% to $15.1 billion by 2010.)
MORE ON THIS TOPIC